===
EQS Voting Rights Announcement: SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act]
with the objective of Europe-wide distribution
2024-05-17 / 15:28 CET/CEST
Dissemination of a Voting Rights Announcement transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Notification of Major Holdings
1. Details of issuer


Name: SCHOTT Pharma AG & Co. KGaA

Street: Hattenbergstraße 10

Postal code: 55122

City: Mainz
Germany

Legal Entity Identifier (LEI): 529900TU48UE99NHEY88
2. Reason for notification


X Acquisition/disposal of shares with voting rights

Acquisition/disposal of instruments

Change of breakdown of voting rights

Other reason:
3. Details of person subject to the notification obligation


Legal entity: SMALLCAP World Fund, Inc.
City of registered office, country: Lutherville Timonium, United States of America (USA)
4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3.



5. Date on which threshold was crossed or reached:


15 May 2024
6. Total positions

% of voting rights % of voting rights through     Total of 
attached to shares                instruments    both in %        Total number of voting rights 
(total of 7.a.)   (total of 7.b.1 + 7.b.2)      (7.a. +             pursuant to Sec. 41 WpHG 

7.b.)

New 3.06 % 0.17 % 3.23 % 150614616

Previous n/a % n/a % n/a % /
notification
7. Details on total positions a. Voting rights attached to shares (Sec. 33, 34 WpHG)


ISIN Absolute In %

Direct Indirect Direct Indirect
(Sec. 33 WpHG) (Sec. 34 WpHG) (Sec. 33 WpHG) (Sec. 34 WpHG)

DE000A3ENQ51 4603936 0 3.06 % 0 %

Total 4603936 3.06 %
b.1. Instruments according to Sec. 38 (1) no. 1 WpHG


Type of instrument Expiration or maturity date Exercise or conversion Voting rights absolute Voting rights in %
period

0 0 %

Total 0 0.00 %
b.2. Instruments according to Sec. 38 (1) no. 2 WpHG

Type of instrument             Expiration or      Exercise or         Cash or physical     Voting rights       Voting 
maturity date      conversion period   settlement                absolute  rights in % 

Rights to recall lent shares Physical 260429 0.17 %
of Common Stock settlement
Total 260429 0.17 %
8. Information in relation to the person subject to the notification obligation


X Person subject to the notification obligation is not controlled nor does it control any other
undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).

Full chain of controlled undertakings starting with the ultimate controlling natural person or legal
entity:

Name               % of voting rights (if at   % of voting rights through instruments (if  Total of both (if at least 
least 3% or more)                         at least 5% or more)                 5% or more) 

9. In case of proxy voting according to Sec. 34 para. 3 WpHG (only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG) Date of general meeting: Holding total positions after general meeting (6.) after annual general meeting:


Proportion of voting rights Proportion of instruments Total of both

% % %
10. Other explanatory remarks:



Date


16 May 2024

===
-----------------------------------------------------------------------------------------------------------------------

2024-05-17 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com

-----------------------------------------------------------------------------------------------------------------------

===

Language:     English 
Company:      SCHOTT Pharma AG & Co. KGaA 

Hattenbergstraße 10
55122 Mainz
Germany

End of News EQS News Service
===
1906179 2024-05-17 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1906179&application_name=news

END) Dow Jones Newswires

May 17, 2024 09:28 ET (13:28 GMT)